Spiropyran-Modulated Quinone-Mediated Transmembrane Redox
A R T I C L E S
from the filtrate by vacuum rotary evaporation. The residue was
dissolved in CH2Cl2 and purified by flash column chromatography on
silica gel to give 3.2 g (64%) of compound 1 as a yellow viscous fluid.
1H NMR (300 MHz, CDCl3): δ 0.4-1.3 (m, 25H, C12H25), 6.6 (m,
2H, 2′′′,6′′′-C6H6), 6.76 (m, 1H, 6-AQ), 6.92 (m, 2H, 3′′′,5′′′-C6H6),
7.2 (m, 2H, 3,7-AQ), 7.3 (m, 1H, 8-AQ), 7.56 (d, 1H, 2-AQ), 7.79 (m,
1H, 4-AQ) (labeling as defined for compound 7).
Compound 6 (9,10-Dihydro-N-(1,3-dihydro-1,3,3-trimethyl-6-
nitrospiro[2H-1-benzopyran-2,2′-(2H)-indole])-9,10-dioxoanthracene-
1-carboxamide) (SP-AQ): A solution of 1.08 g (2.6 mmol) of
compound 4 and 0.43 g (2.6 mmol) of 2-hydroxy-5-nitrobenzaldehyde
in 200 mL of MeOH was refluxed for 4 h. After removal of solvent by
rotoevaporation, the residue was dissolved in 100:3 (v/v) CH2Cl2/CH3-
OH and purified by flash chromatography on silica gel to give 1.02 g
(67%) of compound 6 (SP-AQ) (mp > 200 °C). MS m/z 571.5. Calcd
Compound 2 (5-(4-Dodecylphenoxy)-9,10-dihydro-9,10-dioxoan-
thracence-1-carbonitrile): 3.2 g of compound 1 (6.4 mmol) and 0.85
g of cuprous cyanide (9.5 mmol) were stirred at reflux in 50 mL of
dimethylacetamide for 4 h under N2. The hot solution was poured into
700 mL of vigorously stirred water to give the copper(I) complex of
the product. The crude complex was decomposed with 200 mL of
boiling 4 N nitric acid for 4 h to yield 2.9 g (92%) of compound 2 as
a yellow solid. 1H NMR (300 MHz, CDCl3): δ 0.4-1.3 (m, 25H,
C12H25), 6.65 (m, 2H, 2′′′,6′′′-C6H6), 6.82-7.2 (m, 3H, 6-AQ + 3′′′,5′′′-
C6H6), 7.3 (m, 2H, 3,7-AQ), 7.6 (t, 1H, 8-AQ), 7.78 (d, 1H, 4-AQ),
8.2 (d, 1H, 2-AQ) (labeling as defined for compound 7).
for C34H25N3O6: C, 71.44; H, 4.41; N, 7.35. Found: C, 71.28; H, 4.84;
N, 7.14. 1H NMR (300 MHz, d6-DMSO): δ 1.15 (s, 3H, 8′′-CH3-
indoline), 1.23 (s, 3H, 8′′-CH3-indoline), 2.67 (s, 3H, 1′′-CH3-indoline),
6.01 (d, 1H, 2′-oxazine), 6.64 (d, 1H, 3′′-indoline), 6.9 (d, 1H,
3′-oxazine), 7.35 (d, 1H, 8′-oxazine), 7.58 (m, 2H, 4′′,6′′-indoline), 7.9-
8.05 (m, 3H, 3,6,7-AQ), 8.2-8.5 (m, 5H, 2,4,5,8-AQ; 7′-oxazine), 8.78
(s, 1H, 5′-oxazine), 10.55(s, 1H, NH).
Compound 7 (5-(4-Dodecylphenoxy)-9,10-dihydro-N-(1,3-dihy-
dro-1,3,3-trimethyl-6-nitrospiro[2H-1-benzopyran-2,2′-(2H)-indole])-
9,10-dioxoanthracene-1-carboxamide) (SP-AQ-C12): A solution of
0.205 g (0.3 mmol) of compound 5 and 0.05 g (0.3 mmol) of 2-hydroxy-
5-nitrobenzaldehyde in 20 mL of MeOH was refluxed for 4 h. After
removal of solvent by rotoevaporation, the residue was dissolved in
100:2 (v/v) CH2Cl2/CH3OH and purified by flash chromatography on
silica gel to give 0.1 g (40%) of compound 7 (SP-AQ-C12) (mp 112-
114.5 °C). MS m/z 831.9. Calcd for C52H53N3O7: C, 75.07; H, 6.42;
Compound 3 (5-(4-Dodecylphenoxy)-9,10-dihydro-9,10-dioxoan-
thracence-1-carboxylic Acid): 2.8 g of compound 2 (5.7 mmol) were
added to 200 mL of 70% sulfuric acid, and the mixture was stirred at
reflux for 1.5 h, after which the hot solution was poured onto ice. The
precipitate was collected by filtration, washed with water, and
resuspended in 200 mL of CH2Cl2. This slurry was filtered, and the
filtrate was dried over anhydrous sodium sulfate. The crude product
was isolated by rotoevaporation, dissolved in 100:5 (v/v) CH2Cl2/CH3-
OH, and purified by flash chromatography on silica gel to give 1.3 g
1
(45%) of compound 3. H NMR (300 MHz, CDCl3): δ 0.4-1.3 (m,
25H, C12H25), 6.65 (m, 2H, 2′′′,6′′′-C6H6), 6.83 (s, 1H, 6-AQ), 6.92
(m, 2H, 3′′′,5′′′-C6H6), 7.15-7.4 (m, 3H, 3,7,8-AQ), 7.65 (s, 1H, 4-AQ),
7.95 (s, 1H, 2-AQ) (labeling as defined for compound 7).
Compound 4 (9,10-Dihydro-N-(1,3,3-trimethyl-2-methylenein-
dolin-5-yl)-9,10-dioxoanthracene-1-carboxamide): A mixture of 1.73
g (9.2 mmol) of 5-amino-1,3,3-trimethyl-2-methyleneindoline, 1.98 g
(9.2 mmol) of Proton-Sponge (1,8-bis(dimethylamino)naphthalene), and
2.5 g (9.2 mmol) of anthraquinone-1-carbonyl chloride in 150 mL of
dry THF was stirred overnight at room temperature under N2. Following
filtration, the crude product was isolated from the filtrate by rotoevapo-
ration and purified after dissolution in 100:3 (v/v) CH2Cl2/CH3OH and
flash column chromatography on silica gel to give 1.9 g (52%) of
compound 4. 1H NMR (300 MHz, CDCl3): δ 1.32 (s, 6H, 8′′,8′′-CH3-
indoline), 3.03 (s, 3H, 1′′-CH3-indoline), 3.85 (s, 2H, 9′′-CH2-indoline),
6.43 (d, 1H, 3′′-indoline), 7.36 (dd, 1H, 4′′-indoline), 7.51 (d, 1H, 6′′-
indoline), 7.76 (m, 2H, 6,7-AQ), 8.2 (m, 2H, 5,8-AQ), 8.28 (m, 2H,
3,4-AQ), 8.42 (s, 1H, NH), 8.59 (d, 1H, 2-AQ) (labeling as defined
for compound 6).
Compound 5 (5-(4-Dodecylphenoxy)-9,10-dihydro-N-(1,3,3-tri-
methyl-2-methyleneindolin-5-yl)-9,10-dioxoanthracene-1-carbox-
amide): A solution of 6 g (11.7 mmol) of compound 3 and 2.22 g
(12.6 mmol) of 2-chloro-4,6-dimethoxy-1,3,5-triazine in 150 mL of
dry THF was stirred in an ice bath under N2. 1.35 mL (12.6 mmol) of
N-methylmorpholine was then slowly syringe-injected at 4 °C. The
filtrate from this reaction was then added to 1.47 g (7.8 mmol) of
5-amino-1,3,3-trimethyl-2-methyleneindoline and 1.35 mL (12.6 mmol)
of N-methylmorpholine in 50 mL of THF. This solution was stirred at
4 °C for 2 h and then warmed to room temperature for 24 h. After
removal of solvent, the residue was dissolved in 100:3 (v/v) CH2Cl2/
CH3OH and purified by flash column chromatography on silica gel to
N, 5.05. Found: C, 74.89; H, 6.40; N, 5.20. 1H NMR (300 MHz,
CDCl3): δ 0.3-1.5 (m, 31H, C12H25 + 8′′,8′′-CH3-indoline), 2.72 (s,
3H, 1′′-CH3-indoline), 5.85 (d, 1H, 2′-oxazine), 6.48 (d, 1H, 3′′-
indoline), 6.8 (dd, 2H, 2′′′,6′′′- C6H6), 7.02 (d, 2H, 3′′′,5′′′-C6H6), 7.11
(m, 1H, 3′-oxazine), 7.3 (m, 2H, 8′-oxazine + 4′′-indoline), 7.4-7.68
(m, 5H, 6′′-indoline + 3,6,7,8-AQ), 7.9-8.12 (m, 4H, 2,4,-AQ + NH
+ 7′-oxazine), 8.42 (s, 1H, 5′-oxazine).
13C NMR spectra for all of the synthesized compounds are given in
the Supporting Information. 9,10-Anthraquinone was reduced to the
corresponding diol by H2O2-induced reduction with sodium borohydride,
as described in the literature.16
1
Vesicle Preparation. Phosphatidylcholine (PC) was extracted from
fresh hen’s egg yolk and purified by column chromatography following
literature procedures.17 Aqueous suspensions of PC and the dopants
(SP, AQ, SP-AQ, or SP-AQ-C12) in 40 mM Tris buffer, pH 8.0,
give 2.8 g (52.5%) of compound 5. H NMR (300 MHz, CDCl3): δ
0.3-1.4 (m, 31H, C12H25 + 8′′,8′′-CH3-indoline), 3.03 (s, 3H, 1′′-CH3-
indoline), 3.85 (s, 2H, 9′′-CH2-indoline), 6.42 (d, 1H, 3′′-indoline), 6.96
(m, 2H, 2′′′,6′′′-C6H6), 7.07 (s, 1H, 6-AQ), 7.2-7.4 (m, 4H, 3′′′,5′′′-
C6H6 + 4′′,6′′-indoline), 7.4-7.68 (m, 3H, 3,7,8-AQ), 7.9 (m, 1H,
4-AQ), 7.98 (s, 1H, 2-AQ), 8.04 (s, 1H, NH) (labeling as defined for
compound 7).
(16) Panson, G. S.; Weill, C. E. J. Am. Chem. Soc. 1955, 22, 120-121.
(17) Singleton, W. S.; Gray, M. S.; Brown, M. L.; White, J. L. J. Am. Oil Chem.
Soc. 1965, 42, 53-56.
9
J. AM. CHEM. SOC. VOL. 128, NO. 3, 2006 827